Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Barriers still stand in the way of making treatment available to all who need it.
Updated hepatitis C recommendations emphasize screening for key populations and treatment for all people living with HCV.
A joint statement from the Infectious Diseases Society of America and the HIV Medicine Association to President Trump and Congress.
Hepatitis C treatment has improved dramatically in recent years.
From the HCV Guidelines,"According to the guidance, successful hepatitis C treatment results in sustained virologic response
Daraprim treats toxoplasmosis, a parasitic infection deadly for people with HIV. Turing Pharmaceuticals raised price from $13.50 to $750.
Guidelines for hepatitis C have updated once again to emphasize that those with advanced fibrosis or compensated cirrhosis should be treated f...
Hep C treatment guidelines have been revised to underline that treatment will benefit almost all HCV-positive people, regardless of disease se...
AASLD and IDSA’s Recommendations for Testing, Managing, and Treating Hepatitis C y recommend monitoring hepatitis C patients for progression o...
Two clinical groups have issued new hepatitis C treatment guidelines that instructs clinicians on how to prioritize care among patients seekin...
The National Association of Medicaid Directors has denounced as poor and potentially biased the available evidence and guidelines supporting S...
Three major disease associations have launched a website to provide guidance about managing hepatitis C for both clinicians and people living...
Statement from IDSA President David A. Relman, MD, FIDSA, on U.S. Preventive Services Task Force draft recommendations on hepatitis C screenin...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.